Boston Scientific Other Nonoperating Income (Expense), Net increased by 756.5% to $151.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 544.1%, from -$34.00M to $151.00M. Over 2 years (FY 2022 to FY 2024), Other Nonoperating Income (Expense), Net shows an upward trend with a -35.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Large fluctuations can indicate volatility in non-core areas like currency hedging or investment portfolio performance.
The net balance of income and expenses that are not related to the company's primary business operations, such as foreig...
Highly variable across companies depending on the scale of treasury and investment activities.
other_other_nonoperating_income_expense_net_8cd48e| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$9.50M | -$9.50M | -$9.50M | -$9.50M | -$23.25M | -$23.25M | -$23.25M | -$23.25M | $2.00M | -$23.00M | $14.00M | -$9.00M | -$34.00M | $213.00M | -$23.00M | $151.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -144.7% | +0.0% | +0.0% | +0.0% | +108.6% | <-999% | +160.9% | -164.3% | -277.8% | +726.5% | -110.8% | +756.5% |
| YoY Change | — | — | — | — | -144.7% | -144.7% | -144.7% | -144.7% | +108.6% | +1.1% | +160.2% | +61.3% | <-999% | >999% | -264.3% | +544.1% |